Role of AT1 and AT2 receptors in the plasma clearance of angiotensin II

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 3, 1998, Pages 464-469

  Iyer, Shridhar N ^a   Chappell, Mark C ^a   Brosnihan, K Bridget ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Half life; Losartan; Metabolic clearance rate; PD123319; Renin angiotensin system; Sar1 Thr8 Ang II

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; LOSARTAN; ANGIOTENSIN II; ANGIOTENSIN II, SAR(1) THR(8); ANGIOTENSIN II, SAR(1)-THR(8)-; ANGIOTENSIN RECEPTOR; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG HALF LIFE; DRUG RECEPTOR BINDING; ENDOCYTOSIS; ENZYME DEGRADATION; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR DOWN REGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TARGET CELL; ANIMAL; BLOOD; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; HALF LIFE TIME; MALE; PHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; HALF-LIFE; IMIDAZOLES; LOSARTAN; MALE; PYRIDINES; RATS; RATS, INBRED SHR; RECEPTORS, ANGIOTENSIN;

EID: 0031594119     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199803000-00019     Document Type: Article

References (28)

1. Kuczera M, Hilgers KF, Lisson C, et al. Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats. J Hypertens 1991;9:41-8.
2. Okolicany J, McEnroe GH, Koh GY, Lewiski JA, Maack T. Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor. Am J Physiol 1992;263:F546-53.
3. Khairallah PA, Page IH, Bumpus FM, Turker RK. Angiotensin tachyphylaxis and its reversal. Circ Res 1966;29:247-54.
4. Almeida FA, Suzuki RM, Scarborough RM, Lewicki JA, Maack T. Clearance function of type C receptors of atrial natriuretic factor in rats. Am J Physiol 1989;256:R469-79.
5. Ashwell G, Harford J. Carbohydrate-specific receptors in the liver. Annu Rev Biochem 1982;51:531-4.
6. Golstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 1977;81:382-95.
7. Balin BJ, Broadwell RD. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. J Neurocytol 1988; 17:809-26.
8. Sheldon K, Liu D, Ferguson J, Gariepy J. Loligomers: design of de novo peptide-based intracellular vehicles. Proc Natl Acad Sci U S A 1995;92:2056-60.
9. Smith RD, Timmermans PBMWM. Human angiotensin receptor subtypes. Curr Opin Nephrol Hypertens 1994;3:112-22.
10. Swanson GN, Hanesworth JM, Sardinia MF, et al. Discovery of a distinct binding site for angiotensin II-(3-8), a putative angiotensin IV receptor. Regul Pept 1992;40:409-19.
11. Ferrario CM, Santos RAS, Brosnihan KB, et al. A hypothesis regarding the function of angiotensin peptides in the brain. Clin Exp Hypertens [A] 1988;10:107-21.
12. Anderson KM, Murahshi T, Dostal DE, Peach MJ. Morphological and biochemical analysis of angiotensin II internalization in cultured rat aortic smooth muscle cells. Am J Physiol 1993;264: C179-88.
13. Renter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin-(1-7). Peptides 1993;14:679-84.
14. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 1997;29:388-92.
15. Vernace MA, Mento PF, Maita ME, Wilkes BM. Effects of angiotensin receptor subtype inhibitors on plasma angiotensin clearance. Hypertension 1994;23:853-6.
16. Kawabe H, Husain A, Khosla MC, Smeby RR, Bumpus FM, Ferrario CM. Characterization of receptors for angiotensin-induced drinking and blood pressure responses in conscious rats using angiotensin analogs extended at the N-terminal. Neuroendocrinology 1986;42:289-95.
17. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 1994;15: 919-26.
18. Nakamoto H, Ferrario CM, Fuller SB, Robaczwski DL, Winicov E, Dean RH. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension 1995;25:796-802.
19. Kohara K, Tabuchi Y, Senanayake P, Brosnihan KB, Ferrario CM. Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides 1991;12:1135-41.
20. Naden RP, Coultrup S, Arant BS, Rosenfeld CR. Metabolic clearance of angiotensin II in pregnant and nonpregnant sheep. Am J Physiol 1985;249:E49-55.
21. 8)-Ang II in sheep. Life Sci 1981;29:157-63.
22. Chappell MC, Ferrario CM, Tallant EA. Internalization of angiotensin peptides by rat hypothalamic astrocytes [Abstract]. Am J Hypertens 1994;7:81A.
23. Cain MD, Catt KJ, Coghlan JP, Blair-West JR. Evaluation of angiotensin II metabolism in sheep by radioimmunoassay. Endocrinology 1970;86:955-64.
24. Champlain JD, Genest J, Veyratt R, Boucher R. Factors controlling renin in man. Arch Intern Med 1966;117:355-63.
25. Pucell AG, Hodges JG, Sen I, Bumpus FM, Husain A. Biochemical properties of the ovarian granulosa cell type-2 angiotensin II receptor. Endocrinology 1991;128:1947-59.
26. 2) binding sites in R3T3 cells. Mol Pharmacol 1992;40:360-7.
27. Dulin NO, Ernsberger P, Suciu DJ, Douglas JG. Rabbit renal epithelial angiotensin receptors. Am J Physiol 1994;267:F776-82.
28. 4 receptors: specificity and distribution. Kidney Int 1994;46: 1510-2.